Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention

Journal of Cardiovascular Medicine

Volumn 11, Issue 6, 2010, Pages 444-449

  Maioli, Mauro ^a   Toso, Anna ^a   Gallopin, Michela ^a   Leoncini, Mario ^a   Tedeschi, Delio ^a   Micheletti, Carlo ^a   Bellandi, Francesco ^a  

^a MISERICORDIA E DOLCE HOSPITAL   (Italy)

Author keywords

Angiography; Angioplasty; Constrast medium; Contrast induced nephropathy

Indexed keywords

CREATININE; IODIXANOL;

AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; PATIENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, ACUTE; RISK ASSESSMENT; TRIIODOBENZOIC ACIDS;

EID: 77951876332     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328335227c     Document Type: Article

References (25)

1. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105:2259-2264.
2. McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 2006; 98(Suppl):5K-13K.
3. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008; 51:1419-1428.
4. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103:368-375.
5. Gruber L, Mintz GS, Meharn R, Dangas G, Lansky A, Kent KM, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with preexistent chronic disease. J Am Coll Cardiol 2000; 36:1542-1548.
6. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 2002; 39:1113-1119.
7. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 2004; 44:1393-1399.
8. Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004; 93:1515-1519.
9. Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, et al. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 2008; 52:599-604.
10. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
11. Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 2003; 76:513-518.
12. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Comparison of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331:1416-1420.
13. Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol 2000; 11:177-182.
14. Mueller C, Buerkle G, Buettner HJ, Petersen A, Perruchoud AP, Eriksson U, et al. Prevention of contrast-associated nephropathy. Arch Intern Med 2002; 162:329-336.
15. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343:180-184.
16. Cigarroa RG, Lange LA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989; 86:649-652.
17. Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 1999; 9:1602-1613.
18. National Kidney Foundation. K/DOQJ. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl 1):51-237.
19. Briguori C, Colombo A, Violante A, Balestrieri P, Manganelli F, Elia PP, et al. Standard versus double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 2004; 25:206-211.
20. Laskey WK, Jenkins C, Selzer F, Marroquin OC, Wilensky RL, Glaser R, et al. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 2007; 50:584-590.
21. Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol 2004; 44:1763-1771.
22. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy. A clinical and evidence-based approach. Circulation 2006; 113:1799-1806.
23. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospitalacquired renal insufficiency: a prospective study. Am J Med 1983; 74:243-248.
24. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39:930-936.
25. Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44:1780-1785.